Technologiepark Heidelberg GmbH

🚀 Join the PyLadies Southwest for an Afternoon of Insights on Data Privacy and Leadership! Are you ready to dive into the world of data privacy and leadership? Then don't miss Community Conversations: Exploring Data Privacy and Data Leadership! 📊🔐 🌟 Key Highlights: Two inspiring keynotes from top experts in the field ▪️ Katharine Jarmul, acclaimed author on Practical Data Privacy ▪️ Tereza Iofciu, skilled Data Leadership Coach 🎉 After the talks, stick around for pizza, cold drinks, and fantastic networking opportunities with other data enthusiasts and privacy advocates in a relaxed setting! 🍕🥤 📅 November 8, 2024 🕓 4:00 pm 📍 HUB 103, Palo-Alto-Platz 1-3, 69124 Heidelberg Let’s connect, learn, and discuss how to lead and protect data in a digital world. Looking forward to seeing you there! 💬✨ #DataPrivacy #DataLeadership #WomenInTech #HeidelbergEvents #Networking PyLadies , Cansu Cak, Carolin Bischop, Nicolas Poggi, Samira Höhn, KI-Garage, Baden-Württemberg Stiftung GGmbH, Alexander C.S. Hendorf 👋, Pioneers HUB

📣 On Wednesday we hosted "Science & Apero" with Lonza and it was a huge success! 🎤 The speaker (and absolute star!) Yvette Stallwood enchanted the crowd with her talk on how to de-risk #biologics therapeutics at an early stage of #DrugDevelopment and bringing case studies and real life examples, from scientists to scientists! 💥 Thank you, Lonza, for this inspiring and vibrant network event and for visiting #Heidelberg and our Technologiepark Heidelberg GmbH! André H.R. Domin, Markus Bühler, Life Science Accelerator Baden-Württemberg, bioRN Life Science Cluster Rhine-Neckar, Lonza, Martina Elena De Gennaro, and many more.

🚀 Who are Heideberg's most successful founders? 💡 With our second issue of the #Heidelberg Start-up-Magazin #found, we are happy to give you insights of what is happening in the Heidelberg start-up scene at the moment! ✨ Starting with Onuava who is breaking taboos and bringing fertility benefits to the DACH Region. 🎯 Infertility is a challenge that affects 1 in 6 people globally, and 10% of couples in Germany face unplanned childlessness. Yet, the topic remains taboo in both personal and professional environments. That’s where Onuava steps in. 🌐 Founded by Dr. Julia Reichert and Katharina Jung, Onuava is bringing Fertility- and Family-Building-Benefits to the DACH region, offering not just medical and emotional support but also financial aid to employees on their journey to parenthood. Their innovative approach aims to help companies become Talent Magnets by addressing this important issue. 🏆 In recognition of their pioneering work, Onuava proudly received the Heidelberger Gründerpreis 2023. Their vision is already inspiring companies to adopt fertility benefits, improving employee wellbeing and retention. 💬 Want to know more about how Onuava is transforming workplaces? Read the full story in our #found magazin linked in the comments below! 🔗 #FertilityBenefits #FamilyBuilding #Onuava #HeidelbergerGründerpreis2023 #HRInnovation #MentalHealth #BreakingTaboos

🎉 What an incredible day at Life Science Investors Day 2024! 🎉 💥 We are thrilled with the success of this year’s event in Heidelberg, where groundbreaking life science startups and visionary investors gathered to shape the future of healthcare innovation. 🙏 A big thank you to our partners Life Science Accelerator Baden-Württemberg, BioLabs Heidelberg, bioRN Life Science Cluster Rhine-Neckar, HTGF | High-Tech Gründerfonds, BIOPRO Baden-Württemberg GmbH, and Heidelberg Startup Partners e.V.. Your support made this incredible event possible. Together, we’re advancing therapeutics, diagnostics, and digital health! 🤝 Thanks to all teams and investors! Hope to see you again next year! #LSID2024 #LifeScienceInnovation #HealthcareInvesting #VentureCapital #Biotech #ThankYou Heidelberg Startup Partners e.V., Juergen Bauer, André H.R. Domin, Frieder Kern, Prof. Bernhard Küppers, Max Wetterauer, Dr. Raoul Haschke, Michael Gerards, Thomas Prexl, Technologiepark Heidelberg GmbH, Julia Niederbuehl, Clara Jassoy, Angelika Habecker, Stefan Weigandt, Paul Becker, Mathis Palm, Samira Höhn, Cansu Cak, Nicolas Poggi, Julia Schaft, Daniela Weber, Ann-Kristin Mueller, Stefanie Schimmel, Dr. Barbara Jonischkeit, Katrin Stökle, Frank Hensel, Laura Pedroza, Katharina Severin 𝘍𝘰𝘵𝘰𝘴: 𝘚𝘶𝘴𝘢𝘯𝘯𝘦 𝘓𝘦𝘯𝘤𝘪𝘯𝘢

📣 𝗜𝗻𝘃𝗶𝘁𝗮𝘁𝗶𝗼𝗻 𝘁𝗼 𝘁𝗵𝗲 𝟱𝘁𝗵 𝗧𝗿𝗶𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵𝗧𝗲𝗰𝗵 𝗗𝗮𝘆𝘀 arise by BadenCampus, together with its partners from the Life Science Accelerator Baden-Württemberg, the University of Basel, and Quest for health, invites you to the 5th edition of the Trinational HealthTech Days. 💥 This two-day event, combining thematic panels, networking opportunities, and private investor meetings, aims to gather startups and the health innovation ecosystems from the Upper Rhine (FR/DE/CH).   📅 November 7, 2024 ⏰ 9:30am to 6:00pm 📍 Breisach 🌟 Program Highlights: ◾️ Introduction of the trinational consortium members ◾️ Keynote: “Data centricity - Data quality. Integration in existing healthcare environment” by Dr. Michael Lauk, Chief Digital Officer, B. Braun SE ◾️ Panel Discussion: “How can we ensure medical care despite exploding costs?” featuring experts like Michel de Mathelin, University of Strasbourg, Oliver Bailey, IQVIA and Julius Wehrle, Data integration centre, University Hospital Freiburg 💡 Workshops (2:00pm - 3:30pm): Biotech, Medtech und Digital Health with topics like the new Generation Diagnostics and market access strategies or innovative data integration in the times of AI and ChatGPT. 🚀 Take this opportunity to network with leading industry professionals and gain valuable insights into the latest developments in healthcare innovation. We look forward to your participation! #HealthTechDays #HealthcareInnovation #MedTech #DigitalHealth #Biotech #UpperRhineEcosystem

📣 Today is the day and the 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿'𝘀 𝗗𝗮𝘆 𝟮𝟬𝟮𝟰 is happening in the #BDC in #Heideberg! 💥 We are beyond excited to meet so may innovative #startups and experienced #investors. 🚀 We are looking forward to your pitches: mo:re, IRUBIS, BioHive, AdRegeneer, Umlaut.bio GmbH, Phialogics - The immune tolerance company, EpilepsyGTx, Silvacx, DenseImmun, Zelluna Immunotherapy, sync2brain GmbH, aiPTO TechBio, scioDx, POROUS, Allogenetics, REACH Therapeutics, primAAVera, QuantiLight, PsychProdrugs HD, RIANA Therapeutics, InCephalo, FundaMental Pharma, Akribion Therapeutics, Evora. 🙏 Thank you to the great orga team: Markus Bühler, Bodo Brückner, Thomas Prexl, Daniela Weber, Julia Schaft, Stefanie Schimmel, Ann-Kristin Mueller, and Katrin Stökle. 🤝 And many thanks to our partners and contibutors: BIOPRO Baden-Württemberg GmbH, BioRN Life Science Cluster Rhine-Neckar, BioLabs Heidelberg, HTGF | High-Tech Gründerfonds, Heidelberg Startup Partners e.V., Life Science Accelerator Baden-Württemberg and Techniker Krankenkasse. #LifeScienceInvestorsDay #LifeScienceInvestorsDay24 #LifeScience #Innovation #Startup #Investors #Funding

📣 From Vision to Reality: 20 Years of Pioneering Stem Cell Solutions! “𝘞𝘦'𝘷𝘦 𝘣𝘦𝘦𝘯 𝘵𝘦𝘯𝘢𝘯𝘵𝘴 𝘢𝘵 𝘵𝘩𝘦 𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺 𝘱𝘢𝘳𝘬 𝘧𝘰𝘳 𝘢𝘭𝘮𝘰𝘴𝘵 20 𝘺𝘦𝘢𝘳𝘴 𝘯𝘰𝘸. 𝘛𝘩𝘦 𝘤𝘰𝘯𝘵𝘢𝘤𝘵𝘴 𝘩𝘦𝘳𝘦 𝘩𝘢𝘷𝘦 𝘴𝘶𝘱𝘱𝘰𝘳𝘵𝘦𝘥 𝘶𝘴 𝘪𝘯 𝘦𝘷𝘦𝘳𝘺 𝘱𝘰𝘴𝘴𝘪𝘣𝘭𝘦 𝘸𝘢𝘺. 𝘛𝘩𝘪𝘴 𝘸𝘢𝘴 𝘦𝘴𝘱𝘦𝘤𝘪𝘢𝘭𝘭𝘺 𝘷𝘢𝘭𝘶𝘢𝘣𝘭𝘦 𝘪𝘯 𝘵𝘩𝘦 𝘦𝘢𝘳𝘭𝘺 𝘥𝘢𝘺𝘴, 𝘩𝘦𝘭𝘱𝘪𝘯𝘨 𝘶𝘴 𝘧𝘪𝘯𝘥 𝘴𝘶𝘪𝘵𝘢𝘣𝘭𝘦 𝘱𝘳𝘦𝘮𝘪𝘴𝘦𝘴. 𝘛𝘩𝘦 𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺 𝘱𝘢𝘳𝘬 𝘦𝘷𝘦𝘯 𝘢𝘭𝘭𝘰𝘸𝘦𝘥 𝘶𝘴 𝘵𝘰 𝘪𝘯𝘴𝘵𝘢𝘭𝘭 𝘢 𝘤𝘭𝘦𝘢𝘯𝘳𝘰𝘰𝘮 𝘪𝘯 𝘰𝘶𝘳 𝘣𝘶𝘪𝘭𝘥𝘪𝘯𝘨—𝘴𝘰𝘮𝘦𝘵𝘩𝘪𝘯𝘨 𝘧𝘢𝘳 𝘧𝘳𝘰𝘮 𝘨𝘶𝘢𝘳𝘢𝘯𝘵𝘦𝘦𝘥.”, says Christoph Ganss M.D., CEO of RHEACELL GmbH & Co. KG. 🚀 Dr. med. Christoph Ganss has been on a mission for nearly 20 years: to offer hope to patients suffering from severe diseases that lack effective treatments. With RHEACELL GmbH & Co. KG, based in #Heidelberg, he's leading the development of innovative stem cell therapies that could provide a lifeline to those in need. 🔬 About RHEACELL RHEACELL GmbH & Co. KG develops innovative stem cell therapies for patients suffering from severe immune and inflammatory diseases, aiming to bring hope where no treatment exists. 💡 🏆 Key Milestones From launching TICEBA with Harvard’s Prof. Dr. Markus Frank to pivoting towards therapy development, and achieving national approval for the therapies. 🌍 Why Heidelberg? The city offers a thriving research environment and a high quality of life, attracting top talent. 📃 Read the full interview with Christoph Ganss M.D. at our website linked in the comments below. #Innovation #CellTherapy #Biotech #Entrepreneurship #StemCells #HealthcareTransformation

📣 Join us tomorrow for good food, good vibes and a great keynote at the Up2B Accelerator #Up2BBQ! 🔥 At the #Up2BBQ on October 9, 2024 Esther Mangler from mangler+noller – The Bridge to Brands is sharing her tips on 𝗕𝟮𝗕 𝗯𝗿𝗮𝗻𝗱𝗶𝗻𝗴 𝗳𝗼𝗿 𝘀𝘁𝗮𝗿𝘁𝘂𝗽𝘀. If you're curious about how to make your brand stand out, don't miss this session! 📅 October 9, 2024 | 4:00 pm 📍 MAFINEX Technologiezentrum, Mannheim ❗ 𝗚𝗲𝘁 𝘆𝗼𝘂𝗿 𝘁𝗶𝗰𝗸𝗲𝘁 𝗻𝗼𝘄: https://lnkd.in/eHTj6ByP 🤝 The contributors: Start-up BW, NEXT MANNHEIM, Technologiepark Heidelberg GmbH, innoWerft. 👥 The Up2B team Fiona Preisler, Frauke Bothe-Anstädt, Mathis Palm, Samira Höhn, Viviane Laube, Rebecca Föhner and Yannick Ishimwe are looking forward to meeting you at the Up2BBQ!

📣 Scaling Innovation: How Technologiepark Heidelberg GmbH Fuels Medical Breakthroughs! "𝘛𝘩𝘦 𝘏𝘦𝘪𝘥𝘦𝘭𝘣𝘦𝘳𝘨 𝘛𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺 𝘗𝘢𝘳𝘬 𝘪𝘴 𝘤𝘳𝘶𝘤𝘪𝘢𝘭 𝘧𝘰𝘳 𝘰𝘶𝘳 𝘧𝘶𝘵𝘶𝘳𝘦. 𝘞𝘪𝘵𝘩 𝘤𝘶𝘳𝘳𝘦𝘯𝘵 𝘧𝘶𝘯𝘥𝘪𝘯𝘨 𝘰𝘧 €22 𝘮𝘪𝘭𝘭𝘪𝘰𝘯, 𝘸𝘦'𝘷𝘦 𝘭𝘦𝘧𝘵 𝘰𝘶𝘳 '𝘪𝘯𝘤𝘶𝘣𝘢𝘵𝘰𝘳 𝘱𝘩𝘢𝘴𝘦' 𝘢𝘵 𝘵𝘩𝘦 𝘶𝘯𝘪𝘷𝘦𝘳𝘴𝘪𝘵𝘺 𝘩𝘰𝘴𝘱𝘪𝘵𝘢𝘭 𝘢𝘯𝘥 𝘧𝘰𝘶𝘯𝘥 𝘯𝘦𝘸 𝘧𝘢𝘤𝘪𝘭𝘪𝘵𝘪𝘦𝘴 𝘪𝘯 𝘵𝘩𝘦 𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺 𝘱𝘢𝘳𝘬 𝘧𝘰𝘳 𝘰𝘶𝘳 𝘶𝘱𝘤𝘰𝘮𝘪𝘯𝘨 𝘨𝘳𝘰𝘸𝘵𝘩 𝘴𝘵𝘢𝘨𝘦. 𝘈𝘭𝘭 𝘴𝘵𝘢𝘬𝘦𝘩𝘰𝘭𝘥𝘦𝘳𝘴 𝘸𝘰𝘳𝘬𝘦𝘥 𝘵𝘰𝘨𝘦𝘵𝘩𝘦𝘳 𝘸𝘪𝘵𝘩 𝘨𝘳𝘦𝘢𝘵 𝘦𝘹𝘱𝘦𝘳𝘪𝘦𝘯𝘤𝘦 𝘢𝘯𝘥 𝘳𝘦𝘢𝘥𝘪𝘯𝘦𝘴𝘴 𝘵𝘰 𝘭𝘦𝘢𝘳𝘯. 𝘏𝘦𝘳𝘦, 𝘸𝘦 𝘩𝘢𝘷𝘦 𝘦𝘯𝘰𝘶𝘨𝘩 𝘴𝘱𝘢𝘤𝘦 𝘵𝘰 𝘦𝘹𝘱𝘢𝘯𝘥 𝘢𝘯𝘥 𝘪𝘯𝘵𝘦𝘳𝘯𝘢𝘵𝘪𝘰𝘯𝘢𝘭𝘪𝘻𝘦 𝘰𝘶𝘳 𝘤𝘰𝘮𝘱𝘢𝘯𝘺.", says Prof. Dr. Patrick Most, Head of Molecular and Translational Cardiology at University Hospital Heidelberg (UKHD). ✨ Prof. Dr. Patrick Most is at the forefront of medical innovation. Leading the Section of Molecular and Translational Cardiology, he has founded the biotech spin-off AaviGen GmbH which is focused on developing gene therapies for cardiovascular and cardiopulmonary diseases. 🔬 His journey: After receiving a DFG training fellowship, Prof. Most started his academic career with a tenure-track professorship at the Thomas Jefferson University in Philadelphia. In 2010, he returned to Germany as a Professor in #Heidelberg, focusing on gene therapy for heart diseases. 💡 AaviGen GmbH is dedicated to developing gene therapies for cardiovascular diseases. Moving from academia to entrepreneurship is challenging, but necessary to bring innovations from lab to patient care. 🌱 The Technologiepark Heidelberg GmbH provides the space to foster this growth. With support from visionary investors like Dietmar Hopp, Prof. Most and his team are paving the way from lab to patient. It’s all about taking innovative therapies and turning them into real-world patient solutions - the true goal of medical research. 🔭 Vision for the Future? A "Biotech Valley" in Heidelberg - a hub for biomedicine and start-ups to thrive, attracting investors and pushing bold innovations forward. 📃 Read the full interview with Prof. Dr. Patrick Most at our website linked in the comments below. #BiotechInnovation #GeneTherapy #TechTransfer #StartupGrowth #HealthcareInnovation

📣 Calling All Early-Stage B2B Startups! 🚀 The Up2B Accelerator #Exploration program is your gateway to success. In over 3+2 challenging weeks, you'll define your problem-solution fit, understand customer needs, and refine your business model. 🗓️ Program Dates: Bootcamp: November 4th - 22nd, 2024 Masterclass: December 2nd - 13th, 2024 What’s in it for you? ✅ Hands-on workshops, 1-on-1 mentorship & expert guidance ✅ Demo Day to pitch to our network of investors & corporates ✅ Feedback from experienced mentors ✅ Gain insights into all relevant business areas ✅ Access to a network of potential customers Who should apply? 💡 Startups in Industry Tech, Energy, Agriculture, Mobility, IT, or SaaS 📈 Early-stage or within the first year of founding 🚀 B2B-focused startups with a product in prototype, pilot, or MVP stage 🌍 Ready to make the world a better place! 📝 Deadline to apply: October 13th, 2024 at 23:59! 🔗 Don’t miss out! Apply now via the link in the comments. 🤝 Further contributors: Start-up BW, NEXT MANNHEIM, and innoWerft. 👥 The Up2B Accelerator team: Fiona Preisler, Frauke Bothe-Anstädt, Mathis Palm, Samira Höhn, Viviane Laube. #Up2BExploration #B2BStartups #ProblemSolutionFit #Mentorship #DemoDay #Entrepreneurship #Startups